SCHEMBL10684552

SCHEMBL10684552

C=CC(c1ccccn1)n1ccnc1S

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ KCNA5 P22460 5/20 0.35
▸ KCNE1 P15382 2/20 0.35
▸ CYP17A1 P05093 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.31
▸ KCNH2 Q12809 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10399939 0.81 CYP17A1 (0.42) SLC6A2SLC6A4SLC6A3CYP17A1
SCHEMBL27759745 0.76 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL2547222 0.69 KCNA5 (0.65) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL253431 0.68 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL11800360 0.67 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL6160196 0.67 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL4559171 0.66 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL9633065 0.65 MAPT (0.49) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL4759333 0.64 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL11034374 0.64 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3KCNA5KCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4761480-A DOPAMINE-BETA-HYDROXYLASE INHIBITORS SMITHKLINE BECKMAN CORPORATION (US) 1988-08-02 — — US disclosed
EP-0214740-A2 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1987-03-18 — — EP disclosed
US-4634711-A ENZYME INHIBITORS SMITHKLINE BECKMAN CORPORATION (US) 1987-01-06 — — US disclosed
Send feedback